Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Incoming CFO Jon Johnsson appointed Deputy CEO of Bonava

On 26 June 2024, Bonava announced that Jon Johnsson had been appointed the new CFO and member of Bonava’s Executive Management Group. Bonava’s Board of Directors has today decided to also appoint Jon Johnsson as Deputy CEO of Bonava. He will assume the roles of Deputy CEO and CFO on 2 January 2025.Jon Johnsson has more than 20 years’ experience as CFO and from other leading roles in finance and accounting at companies including Atlas Copco, Geely and most recently as CFO of Karo Healthcare.   For more information, please contact:   Mats Jönsson, Chairman of the Board mats.

Embla Medical: Financial Calendar 2025

Announcement no. 13/2024 Reykjavik, Iceland/Copenhagen, Denmark, December 6, 2024. Embla Medical (Nasdaq Copenhagen: EMBLA), a leading global provider of innovative mobility solutions, today published its financial calendar for 2025. Financial Calendar 2025 5 February 2025                       Interim Report Q4 2024/2024 Annual Report 12 March 2025                         2025 Annual General Meeting 29 April 2025                            Interim Report Q1 2025 22 July 2025                             Interim Report Q2 2025 21 October 2025

Notice of General Meeting in Phase Holographic Imaging PHI AB (publ)

The shareholders of Phase Holographic Imaging PHI AB (publ), (“the Company”), reg.no. 556542-7811, are hereby invited to attend the general meeting on 8 January 2025 at 15.00 at the Company´s office at Skiffervägen 48 in Lund.Right to participate and notification Shareholders who wish to participate in the general meeting must: · be entered into the share register maintained by Euroclear Sweden AB on 23 December 2024; · notify their participation to the Company no later than 30 December 2024. Notification of participation can be made by e-mail to ir@phiab.se. Notification can

Warrants of series TO 10 were exercised to approximately 69 percent and ExpreS2ion receives approximately SEK 10 million

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, WITHIN OR TO THE UNITED STATES, AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SOUTH AFRICA, RUSSIA, SOUTH KOREA, SWITZERLAND OR IN ANY OTHER JURISDICTION WHERE SUCH RELEASE, DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR ANY OTHER MEASURES. Hørsholm, Denmark, 6 December 2024 - Today ExpreS2ion Biotech Holding AB ("ExpreS2ion" or the "Company") announces the outcome of the exercise of warrants of series TO 10, which were issued in connection with the Company'

Aker Solutions ASA: Financial calendar

December 6, 2024 – Financial calendar for Aker Solutions ASA 2025:FINANCIAL YEAR 202411.02.2025 – Quarterly report Q4 202404.04.2025 – Annual report 2024 FINANCIAL YEAR 202528.04.2025 – Annual General Meeting30.04.2025 – Quarterly report Q1 202511.07.2025 – Quarterly report Q2 and Half-year report 202531.10.2025 – Quarterly report Q3 2025 This information is published pursuant to the requirements set out in the Continuing Obligations. ENDS

ADDvise receives allocation decision worth approximately SEK 72 million

ADDvise Group’s subsidiary Hettich Labinstrument AB has received an allocation decision from Region Stockholm worth approximately SEK 72 million. The allocation decision involves the delivery of blood specimen collection equipment over a four-year period, commencing in May 2025. The allocation decision can be appealed up until December 20, 2024. For further information, please contact: Staffan Torstensson, CEO+46 704 33 20 19staffan.torstensson@addvisegroup.se Important information This information is information that ADDvise Group AB is required to disclose under the EU

Fourteen new trains to drive First Rail open access growth

FIRSTGROUP PLC fourteen new trains to drive First Rail open access growth FirstGroup plc (the ‘Group’) is pleased to announce that it has entered into a Lease Agreement with Angel Trains Limited (‘Angel Trains’) and Hitachi Rail Limited (‘Hitachi’) for the lease of 14 new trains. · The Group has signed an agreement with Angel Trains and Hitachi to lease 14 new five-car class 80X Hitachi electric, battery electric or bi-mode trains (70 cars in total) at a cost of c.£500m including maintenance, over a ten year lease period · The trains will be manufactured by Hitachi in County

Form 8.3 - Britvic plc

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1.         KEY INFORMATION (a) Full name of discloser: Magnetar Capital Partners LP(b) Owner or controller of interests and shortpositions disclosed, if different from 1(a):    The naming of nominee or vehicle companies isinsufficient.  For a trust, the trustee(s),settlor and beneficiaries must be named.(c) Name of offeror/offeree in relation to whose Britvic plc

Endre O. Sund to step down as Chair of the Board in Capsol in 2025

Endre O. Sund (b. 1950), Chair of the Board at Capsol Technologies ASA, has notified the Nomination Committee that he will not seek re-election when his term concludes in 2025. Sund has been an integral part of Capsol’s growth journey since joining the Board of Directors in 2018 and serving as Chair since 2020.   “Over the past few years, we have commercialized carbon capture technologies that enable emitters to make CCS investments profitable, expanded internationally, and built a mature project pipeline with 15 million tons of annual CO2 capture potential. Earlier this year, we

Strangvac is back in stock on all launched markets

Stockholm, December 6, 2024 – Intervacc AB (publ) announces that Strangvac, a vaccine against equine strangles, is now back in stock for delivery in all European markets where the vaccine has been launched. The company applied for Special Batch Release (SBR), to allow for the recently manufactured batches to be available for sale. Today, the company can announce that after receiving approval for SBR in all local markets, Strangvac is available for immediate delivery in all markets where the product has been launched. The procedure and processes, including the Special Batch Release,

LiveCasinoRank Explores How Providers Keep Up with Regional Tastes

Stockholm, Sweden, December 2024 - LiveCasinoRank , a leading website specializing in reviewing online dealer casinos and insight into gambling, today explores how game providers keep up with regional tastes, specifically in Germany, France, and Spain. As the live casino industry grows globally, the LiveCasinoRankk team remains dedicated to providing accurate and relevant information to casino players.Regional Trends Influence in Live Casinos Live casinos are no longer just about replicating the traditional casino floor and feeling. They’re becoming highly

Inify Laboratories AB (publ) - Bulletin from the extraordinary general meeting

Today, December 6, 2024, INIFY Laboratories AB, org. no. 559345-4431 (the "Company") held an extraordinary general meeting. A total of 28,168,336 shares were represented at the general meeting, which corresponds to 62.3 percent of the total number of shares and votes in the Company. Below is a summary of the resolution that were made. The extraordinary general meeting resolved, with the requisite majority, in accordance with the Board of Directors' previously published proposal. Issue authorization The general meeting resolved, in accordance with the Board of Directors' proposal, to

Genova publishes prospectus and applies for admission to trading of green bonds 2024/2027 on Nasdaq Stockholm

Genova Property Group AB (publ) (the "Company" or "Genova") issued on 15 November 2024 subsequent senior unsecured green bonds in an amount of SEK 100 million with maturity in 2027 (the "Green Bonds") under a total framework amount of SEK 650 million with ISIN SE0022725636. In accordance with the terms and conditions of the Green Bonds, Genova has applied for admission to trading of the Green Bonds at Nasdaq Stockholm on the sustainable bond list and the first day of trading at Nasdaq Stockholm is expected to be on or about 10 December 2024. For the purpose of the admission to trading, the

Tangiamo signs 48,000 EUR development agreement with Tech (Macau) Ltd for advanced dice gaming solutions

Tangiamo Touch Technology AB (publ) has entered into a development agreement with Tech (Macau) Ltd, a subsidiary of the gaming equipment and casino service provider Paradise Entertainment, for the development of advanced dice gaming technology. The agreement encompasses the development of Dice Shaking Units (DSU) and Automatic Dice Recognition (ADR) software for integration into electronic gaming machines.The development project has a total value of EUR 48,000 and will be executed in phases from December 2024 to April 2025. The payment structure includes an initial payment of EUR 24,000,

Form 8.3 - Direct Line Insurance Group Plc

FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”)   1. KEY INFORMATION   +----------------------------------------------+-------------------------------+|(a) Full name of discloser: |Ninety One UK Ltd |+----------------------------------------------+-------------------------------+|(b) Owner or controller of interests and short|  ||positions disclosed, if different from

Form 8.3 - Aviva Plc

FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”)   1. KEY INFORMATION   +----------------------------------------+-------------------------------------+|(a) Full name of discloser: |Ninety One UK Ltd |+----------------------------------------+-------------------------------------+|(b) Owner or controller of interests and|  ||short positions disclosed, if different

EQT Life Sciences leads Series A funding round for maternal health company Nua Surgical

· Irish maternal health company Nua Surgical secures €6.5M in Series A funding led by EQT Life Sciences · SteriCISION is the first self-retaining retractor designed specifically for Caesarean section (C-section) surgeries · Proceeds will be used for regulatory approval and commercialization of the SteriCISION C-section retractorEQT Life Sciences is pleased to announce that the EQT Health Economics strategy has invested in Nua Surgical, an Irish medical device company innovating in maternal health. The €6.5 million Series A financing was led by EQT Life Sciences. The round was also

Scandinavian Astor Group shares to be dual listed on Boerse Stuttgart as of 12 December 2024

Scandinavian Astor Group AB (publ) (”Astor Group” or the ”Company”) announces that NGM's application process for the dual listing of Astor Group's shares on Boerse Stuttgart is now finalised. The first day of trading on Boerse Stuttgart is tentatively scheduled for 12 December 2024.“We look forward to being officially welcomed to Boerse Stuttgart at the listing ceremony on 12 December. This will be a milestone in Astor Group's journey to establish ourselves as a leading player in the European market and an opportunity to celebrate our step towards international expansion together with our

Cavendish Hydrogen ASA: Extraordinary general meeting held – new board of directors

Oslo, 6 December 2024: Further to the stock exchange announcements made by Cavendish Hydrogen ASA ("Cavendish", OSE: CAVEN) on 15 November and 5 December 2024, an extraordinary general meeting was held today based on a request from shareholders in accordance with section 5-7 (2) of the Norwegian Public Limited Liability Companies Act.The shareholders' proposal to elect new members to Cavendish's board of directors was approved. Consequently, the board of directors of Cavendish comprises the following members: · Lavrans Grjotheim (chair of the board) · Sheri Shaghayegh Shamlou (board

ASETEK - Transactions of executives and related parties in Asetek shares

Announcement of transactions of executives and related parties in Asetek shares. According to the Market Abuse Regulation art. 19, Asetek A/S (the "Company") announces to have received notifications regarding transactions in the Company's shares and related securities by persons discharging managerial responsibilities and persons closely associated with them. Reference is made to the company announcement of 2 December 2024 regarding the Company's rights issue with pre-emptive subscription rights for the Company's existing shareholders (the "Offering"). The Offering comprises at least

Ahlstrom unveils new sustainable PFAS-free filtration media for Air-Oil Separation with advanced water-repellent properties

AHLSTROM OYJ, PRESS RELEASE, DECEMBER 6, 2024, at 12:00 EET The global industrial filtration market is poised for significant growth in the coming years, driven by the demand for more efficient and sustainable filtration solutions. Within this landscape, the air-oil separator market is projected to grow steadily at over 5% annually over the next decade. Air-oil separators are used in compressors and vacuum pumps, where removing residual lubricating oil is critical for machinery performance, and oil and gas systems that require impurity-free final products of the highest quality. The

Change to risk weight floors for loans secured by Norwegian residential real estate

The Norwegian authorities have decided to increase the minimum requirements on average risk weights for loans secured by Norwegian residential real estate applicable to banks using the internal ratings-based approach (IRB) from 20 to 25 percent, with effect from 1 July 2025. The new minimum requirement will increase the DNB Group’s risk exposure amount (REA) and is estimated to reduce the CET1 ratio by approximately 0.7 percentage points.  The minimum requirement is imposed in accordance with article 458 of the Capital Requirements Regulation and will apply until 31 December 2026. The

NORSE ATLANTIC ASA: New share capital registered

Arendal, 6 December 2024: Reference is made to the stock exchange announcements published by Norse Atlantic ASA (the "Company") on 29 November 2024 regarding the private placement of 19,278,576 new shares in the Company directed towards B T Larsen & Co Ltd at a subscription price of NOK 5.00 per share (the "Subscription Price"), raising gross proceeds of NOK 96,392,880, equal to approx. USD 8.7 million (the "Private Placement"). The share capital increase pertaining to the issuance of the shares in the Private Placement has now been registered with the Norwegian Register of Business

Norwegian to launch four new routes from Stockholm Arlanda Airport ahead of summer 2025

Norwegian continues to expand at Stockholm Arlanda Airport by launching four new direct routes ahead of summer 2025. Bucharest, Porto, Lyon, and Bilbao are added to the overall offer by Norwegian from the airport.Norwegian is to expand their range of direct routes at Stockholm Arlanda Airport ahead of summer 2025 by launching four new destinations, of which Bilbao is brand new. The new direct routes to Bucharest, Porto, Lyon, and Bilbao will all be operated twice a week.   - Norwegian's investment in additional direct routes from Stockholm Arlanda Airport is a clear sign of the

There are no items matching the current filter
There are no more items matching the current filter
Back to top